SETTLEMENT AGREEMENT AND MUTUAL RELEASESettlement Agreement • March 14th, 2013 • Ligand Pharmaceuticals Inc • Pharmaceutical preparations • California
THIS SETTLEMENT AGREEMENT AND MUTUAL RELEASE (“Agreement”) is entered into and effective as of this 31st day of October, 2012 (the “Effective Date”) by and between Ligand Pharmaceuticals Incorporated, for and on behalf of itself and for and on behalf of its shareholders, officers, employees, agents and attorneys, and each of them (“Ligand”) and Chiva Pharmaceuticals, Inc., for and on behalf of itself and for and on behalf of its shareholders, officers, employees, agents and attorneys, and each of them (“Chiva”) (collectively, the “Parties” and individually, “Party”).
AMENDED AND RESTATED LICENSE AGREEMENTLicense Agreement • March 14th, 2013 • Ligand Pharmaceuticals Inc • Pharmaceutical preparations • California
This AMENDED AND RESTATED LICENSE AGREEMENT (the “Agreement”) is executed as of October 31, 2012 (the “Amendment Execution Date”), with an effective date of January 6, 2011 (the “Effective Date”) by and between Ligand Pharmaceuticals Incorporated, a corporation organized under the laws of Delaware and having a place of business at 11119 North Torrey Pines Road, Suite 200, La Jolla, CA 92037 (“Ligand”) and Chiva Pharmaceuticals, Inc. (formerly known as Elite Mind Investments Limited), a corporation organized under the laws of the Cayman Islands whose registered office is situated at Scotia Centre, 4th Floor, P.O. Box 2804, George Town, Grand Cayman KY1-1112, Cayman Islands (“Chiva”). Ligand and Chiva are each referred to herein by name or, individually, as a “Party” or, collectively, as “Parties.”
